Altamira Therapeutics Ltd. (CYTOF): 6-K filed Oct 4, 2024

Form type

6-K

Filing date

Oct 4, 2024

Accession number

0001213900-24-085537

Filer

Altamira Therapeutics Ltd. (CIK 1601936)